Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men

Status unconfirmed · Not applicable

Conditions studied: Anal Cancer, HIV Infections

In brief

This study will investigate the efficacy and safety of the quadrivalent vaccine (Gardasil) against the human papilloma virus (HPV) in HIV (human immunodeficiency virus) infected males.

Key facts

Study ID

NCT00666107

Run by

Southern California Institute for Research and Education

People needed

150

Starts

2008-06-01

Expected to finish

2012-06-01

Last updated by the study team

2012-03-14

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male veterans
• Age 18 or older
• HIV-positive
• Seen regularly in the ID Primary Care Clinic at the VA Long Beach Healthcare System

You may not qualify if…

• None

Where it is running

• VA Long Beach Healthcare System — Long Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.